ArticleFrontiers in immunology2025
Case Report: Necrotizing granulomas in the central nervous system: sarcoidosis masquerading as neurotuberculosis.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurosarcoidosis (NS) can affect patients with or without any systemic involvement. Diagnosis of NS without lung involvement requires (i) a biopsy showing typical non-necrotizing granulomas and (ii) exclusion of tuberculosis by negative culture for M. tuberculosis and PCR amplification techniques. In the absence of microbiological infection, the diagnosis is challenging when granulomas are necrotizing mimicking tuberculosis on histology. We report two cases presenting neurological symptoms and radiological lesions that were concordant with the diagnosis of NS. Nevertheless, brain biopsy showed necrotizing granulomas. Antineutrophil cytoplasmic antibodies (ANCA) showed a negative finding. Given the biopsy results, we started anti-tuberculosis treatment despite negative mycobacterial test results. Lack of improvement suggested the diagnosis of necrotizing sarcoid granulomatosis (NSG). NSG usually presents granulomas, necrosis, and vasculitis, mostly in the lungs. However, these cases presented granulomas with extensive necrosis and vasculitis compatible with NSG strictly limited to the central nervous system. The final diagnosis was NS, as NSG is sometimes understood as presenting a pattern of sarcoidosis, a hypothesis supported by the sustained remission obtained under immunosuppressive treatment. Brain NSG should not rule out the diagnosis of NS and lead to the diagnosis of tuberculosis. NS or NSG should still be evoked, especially if microbiological and immunological investigations are negative and even if the central nervous system is the unique organ involved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.